Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo Controlled Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly Compared to Placebo in Osteoporotic Children Treated With Glucocorticoids.
Conditions
Interventions
Zoledronic acid
Placebo
Locations
12
Australia
Novartis Investigative Site
Westmead, New South Wales, Australia
Novartis Investigative Site
Vancouver, British Columbia, Canada
Novartis Investigative Site
Winnipeg, Manitoba, Canada
Novartis Investigative Site
Ottawa, Ontario, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Start Date
December 4, 2008
Primary Completion Date
March 5, 2018
Completion Date
March 5, 2018
Last Updated
September 2, 2020
NCT07474571
NCT07254429
NCT06731608
NCT04787679
NCT06767150
NCT07281586
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions